- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Camrelizumab
I alt 422 resultater
-
Huazhong University of Science and TechnologyIkke rekrutterer endnuAvanceret eller metastatisk EP-NECKina
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RekrutteringGestationel trofoblastisk neoplasiKina
-
Yue HanJiangsu HengRui Medicine Co., Ltd.RekrutteringHAIC kombineret med Camrelizumab og TKI for ikke-operabelt hepatocellulært karcinom efter TACE-svigtIkke-operabelt hepatocellulært karcinomKina
-
Jiangxi Provincial Cancer HospitalRekruttering
-
Sun Yat-sen UniversityRekrutteringParanasal bihulekræft | Induktionskemoterapi | Camrelizumab | Kræft i næsehulen | Intensitetsmoduleret strålebehandling | Samtidig kemoterapiKina
-
Fudan UniversityIkke rekrutterer endnuMave-neoplasmer | Gastroøsofageal Junction AdenocarcinomKina
-
Wuhan Union Hospital, ChinaJiangsu HengRui Medicine Co., Ltd.; CSPC ZhongQi Pharmaceutical Technology...Ikke rekrutterer endnu
-
Wei JiangWuzhou Red Cross Hospital; Guangxi Nanxishan Hospital; Laibin People's Hospital og andre samarbejdspartnereRekrutteringNasopharyngealt karcinomKina
-
Fudan UniversityRekruttering
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.Ikke rekrutterer endnuDLBCL | Primært ekstranodal lymfom
-
Aiping ShiRekrutteringTredobbelt negativ brystkræft (TNBC)Kina
-
Tianjin Medical University Cancer Institute and...RekrutteringAvanceret HER2 negativ brystkarcinom | HRD+brystkræftKina
-
Shengjing HospitalRekrutteringHER2-positiv mavekræftKina
-
Shanghai Jiao Tong University School of MedicineRekrutteringOralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapi | Anti-VEGFRKina
-
Guangxi Medical UniversityJiangsu HengRui Medicine Co., Ltd.RekrutteringHepatocellulært karcinomKina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRekruttering
-
Xijing HospitalRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Feng WangIkke rekrutterer endnu
-
Peking Union Medical College HospitalRekrutteringHepatocellulært karcinom | PD-1 inhibitor | RegorafenibKina
-
Sichuan UniversityIkke rekrutterer endnuCarrelizumab Plus Lenvatinib kombineret med TACE | Borderline resektabelt hepatocellulært karcinomKina
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Zhang Bi Xiang, MDRekrutteringHyperbar iltterapi | Kombination af immunterapi | Hepatocellulært karcinom ikke-resektabeltKina
-
West China HospitalRekrutteringBRAF V600E-muteret /MSS Metastatisk kolorektal cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) kombineret med PD-1 monoklonalt antistofKina
-
Eye & ENT Hospital of Fudan UniversityChinese Academy of Medical SciencesRekrutteringTilbagevendende nasopharyngeal karcinomKina
-
Shanghai Zhongshan HospitalIkke rekrutterer endnu
-
Shanghai Chest HospitalIkke rekrutterer endnu
-
Nanfang Hospital of Southern Medical UniversityRekrutteringHepatocellulært karcinomKina
-
Zhou ChengzhiJiangsu Hengrui Pharmaceutical Co., Ltd.RekrutteringSmåcellet lungekræft i omfattende stadieKina
-
The First Affiliated Hospital of Zhengzhou UniversityIkke rekrutterer endnuEsophageal pladecellekarcinom
-
Di WuRekruttering
-
Fudan UniversityRekrutteringNasopharyngealt karcinom | Nasopharyngeal cancerKina
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Sun Yat-sen UniversityRekrutteringTilbagevendende livmoderhalskræft | Stadie IVB livmoderhalskræft | Vedvarende livmoderhalskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Beijing Chest HospitalIkke rekrutterer endnu
-
Shanghai Zhongshan HospitalIkke rekrutterer endnuIkke-operabelt hepatocellulært karcinom
-
Henan Cancer HospitalRekrutteringAvanceret gastrisk karcinomKina
-
Sun Yat-sen UniversityGuangdong Provincial People's Hospital; Affiliated Cancer Hospital & Institute... og andre samarbejdspartnereRekrutteringNasopharyngealt karcinomKina
-
Peking UniversityIkke rekrutterer endnuThorax esophageal pladecellecarcinomKina
-
Ruijin HospitalRekrutteringHepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)Kina
-
Zhejiang UniversityRekrutteringHepatocellulært karcinomKina
-
Jiangsu Cancer Institute & HospitalRekrutteringAvanceret tyktarmskræftKina
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.RekrutteringHoved- og halskræft | Planocellulært karcinomKina
-
Wuhan Union Hospital, ChinaRekruttering
-
Wuhan Union Hospital, ChinaRekrutteringBlødt vævssarkom | Neoplasmer, bindevæv og blødt væv | Sarkom metastatisk | Sarkom, blødt vævKina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Ikke rekrutterer endnuTredobbelt negativ brystkræftKina
-
Henan Cancer HospitalRekrutteringSmåcellet lungekarcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuMavekræft, HIPEC, Anti-PD-1 antistof Camrelizumab (SHR-1210), kemoterapi og kirurgiKina
-
Harbin Medical UniversityIkke rekrutterer endnuLungemetastaser | Kolorektal cancer metastatisk | Levermetastaser